Literature DB >> 7306226

Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.

T Ishizaki, Y Horai, G Koya, K Matsuyama, S Iguchi.   

Abstract

Acetylator phenotype and metabolic disposition of isoniazid (INH) were studied in 19 Japanese (a population shown to be 11.5% slow acetylators) patients with spontaneous systemic lupus erythematosus (SLE) and 19 healthy controls. Subjects with the elimination half-life (t1/2) of INH of 2.0 hours or less were considered rapid and those of 2.2 hours or more were slow acetylators. Results of phenotyping showed that 17 of 19 SLE patients were rapid, 1 slow, and 1 indeterminate, whereas 18 of the controls were rapid and 1 indeterminate. When phenotyped according to another reported antimode (107 or 110 minutes), 3 of the patients and 2 of the controls were slow and the remainder were all rapid acetylators. The distribution of INH t1/2, acetyl INH to INH ratios in urine and plasma, and hydrazine compounds in urine measured with gas chromatography mass spectrometry was similar between the two groups, except for 1 patient who was definitely classified as a slow acetylator. The relationship between phenotype distribution and possible pathoetiologic factors is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306226     DOI: 10.1002/art.1780241004

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.

Authors:  Y Horai; K Fujita; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients.

Authors:  W L Gent; H I Seifart; D P Parkin; P R Donald; J H Lamprecht
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

4.  Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.

Authors:  Y Horai; T Ishizaki; T Sasaki; G Koya; K Matsuyama; S Iguchi
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  Acetylator polymorphism in discoid lupus erythematosus.

Authors:  J M Ladero; L C Jiménez; M J Fernández; A Robledo
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.